Johnson & Johnson (NYSE:JNJ), the worldwide leader in multiple myeloma therapies, today announced positive topline results from the investigational Phase 3 MajesTEC-3 study. The study evaluates the ...

With a dozen new features landing in the first half of October, Windows 11 Insiders have plenty to explore — from subtle ...

Faulty engineering led to the implosion of an experimental submersible that killed five people on the way to the wreck of the Titanic, the National Transportation ...

Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that it has entered into a partnership with Intelligent Scopes Corporation ...